{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:41:20Z","timestamp":1788428480987,"version":"build-2803163510"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T00:00:00Z","timestamp":1720915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trauma Case Reports"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.tcr.2024.101077","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T19:53:44Z","timestamp":1721073224000},"page":"101077","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Monoclonal antibody anti-sclerostin for treatment of pelvic insufficiency fractures in adult hypophosphatasia: A case report"],"prefix":"10.1016","volume":"53","author":[{"given":"Pierre-Emmanuel","family":"Schwab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Dessain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Milby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcr.2024.101077_bb0005","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.14","article-title":"Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment","volume":"12","author":"Whyte","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.tcr.2024.101077_bb0010","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/jclinpath-2021-207426","article-title":"Hypophosphatasia","volume":"74","author":"Fenn","year":"2021","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.tcr.2024.101077_bb0015","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00223-015-0079-1","article-title":"Alkaline phosphatase and hypophosphatasia","volume":"98","author":"Mill\u00e1n","year":"2016","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.tcr.2024.101077_bb0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s40259-016-0161-x","article-title":"Asfotase alfa in perinatal\/infantile-onset and juvenile-onset hypophosphatasia: a guide to its use in the USA","volume":"30","author":"Scott","year":"2016","journal-title":"BioDrugs"},{"key":"10.1016\/j.tcr.2024.101077_bb0025","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s00223-019-00655-5","article-title":"Sclerostin-antibody treatment decreases fracture rates in axial skeleton and improves the skeletal phenotype in growing oim\/oim mice","volume":"106","author":"Cardinal","year":"2020","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.tcr.2024.101077_bb0030","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00198-022-06523-7","article-title":"Role of Wnt signaling and sclerostin in bone and as therapeutic targets in skeletal disorders","volume":"34","author":"Marini","year":"2023","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.tcr.2024.101077_bb0035","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tcr.2024.101077_bb0040","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1177\/1060028020952764","article-title":"Romosozumab: a novel injectable Sclerostin inhibitor with anabolic and Antiresorptive effects for osteoporosis","volume":"55","author":"Nealy","year":"2021","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.tcr.2024.101077_bb0045","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1172\/JCI83731","article-title":"Efficacy of anti-sclerostin monoclonal antibody BPS804 in adult patients with hypophosphatasia","volume":"127","author":"Seefried","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tcr.2024.101077_bb0050","doi-asserted-by":"crossref","first-page":"526","DOI":"10.52312\/jdrs.2021.82661","article-title":"Bone healing of distal radius nonunion treated with bridge plating with bone graft substitutes in combination with systemic romosozumab administration: a case report","volume":"32","author":"Uemura","year":"2021","journal-title":"Jt. Dis. Relat. Surg."},{"key":"10.1016\/j.tcr.2024.101077_bb0055","article-title":"Successful treatment of humeral shaft nonunion with romosozumab: a case report","volume":"37","author":"Lee","year":"2022","journal-title":"Trauma Case Rep."},{"key":"10.1016\/j.tcr.2024.101077_bb0060","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2106\/JBJS.19.00790","article-title":"A randomized, placebo-controlled study of Romosozumab for the treatment of hip fractures","volume":"102","author":"Schemitsch","year":"2020","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.tcr.2024.101077_bb0065","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.2106\/JBJS.19.01008","article-title":"Romosozumab in skeletally mature adults with a fresh unilateral tibial diaphyseal fracture: a randomized phase-2 study","volume":"102","author":"Bhandari","year":"2020","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.tcr.2024.101077_bb0070","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/mrcr\/rxab018","article-title":"Efficacy of romosozumab for osteoporosis in a patient with osteogenesis imperfecta: a case report","volume":"6","author":"Uehara","year":"2022","journal-title":"Mod. Rheumatol. Case Rep."},{"key":"10.1016\/j.tcr.2024.101077_bb0075","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4158\/EP.14.2.204","article-title":"Treatment of adult hypophosphatasia with teriparatide","volume":"14","author":"Camacho","year":"2008","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.tcr.2024.101077_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10215","article-title":"Outcome of Teriparatide treatment on fracture healing complications and symptomatic bone marrow edema in four adult patients with Hypophosphatasia","volume":"3","author":"Schmidt","year":"2019","journal-title":"JBMR Plus"}],"container-title":["Trauma Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352644024001006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352644024001006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T12:10:25Z","timestamp":1726402225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352644024001006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":16,"alternative-id":["S2352644024001006"],"URL":"https:\/\/doi.org\/10.1016\/j.tcr.2024.101077","relation":{},"ISSN":["2352-6440"],"issn-type":[{"value":"2352-6440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monoclonal antibody anti-sclerostin for treatment of pelvic insufficiency fractures in adult hypophosphatasia: A case report","name":"articletitle","label":"Article Title"},{"value":"Trauma Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcr.2024.101077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101077"}}